Related Experiment Video
Updated: Aug 22, 2026
Examination of Thymic Positive and Negative Selection by Flow Cytometry
Published on: October 8, 2012
Cutting edge: a test of the dominant negative signal model for TCR antagonism
M A Daniels1, S L Schober, K A Hogquist
1Center for Immunology and Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis 55455, USA.
Abstract:
The mechanism by which TCR antagonists interfere with T cell activation is unclear. One popular hypothesis is that incomplete early signaling events induced by these ligands dominantly inhibit the T cell's ability to respond to a copresented agonist ligand. Here we test this "dominant negative" signal hypothesis by studying T cells expressing two distinct MHC class I-restricted TCRs (2C and OT-I). Although responses through each TCR can be efficiently inhibited by their specific antagonists, we found no evidence for "cross-antagonism" in which an antagonist for receptor "A" blocks responses through receptor "B." Such inhibition would have been expected were the dominant negative signaling hypothesis correct, and alternative models for TCR antagonism are discussed.
Insights
TCR antagonists inhibit T cell activation, but not through a dominant negative signal. This study found no cross-antagonism between different T cell receptors and their antagonists, challenging a popular hypothesis.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- T cell activation is crucial for adaptive immunity.
- T cell receptor (TCR) antagonists are known to inhibit T cell responses.
- The precise mechanism of TCR antagonism remains incompletely understood.
Purpose of the Study:
- To investigate the mechanism of TCR antagonism.
- To test the "dominant negative" signaling hypothesis for TCR antagonism.
- To determine if TCR antagonists exhibit cross-antagonism.
Main Methods:
- Studying T cells expressing two distinct MHC class I-restricted TCRs (2C and OT-I).
- Assessing the inhibitory effects of specific TCR antagonists on T cell responses.
- Analyzing for evidence of cross-antagonism between different TCR-antagonist pairs.
Main Results:
- Specific TCR antagonists effectively inhibited responses mediated by their cognate TCRs.
- No evidence of "cross-antagonism" was observed, where an antagonist for one TCR blocked responses of a different TCR.
- These findings contradict the dominant negative signaling hypothesis.
Conclusions:
- The dominant negative signaling model does not fully explain TCR antagonism.
- Alternative mechanisms for TCR antagonism should be considered.
- Understanding TCR antagonism is vital for developing immunotherapies.
